NeoGenomics, Inc.
NEO · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $727M | $661M | +10.1% |
| Operating income | −$116M | −$92.1M | −25.8% |
| Net income | −$108M | −$78.7M | −37.2% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 28, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $209M | $188M | +11.4% |
| Operating income | −$7.90M | −$27.0M | +70.7% |
| Net income | −$7.50M | −$27.1M | +72.3% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was NeoGenomics's revenue in FY2025?
- $727M in FY2025 (Fiscal year ended Dec 31, 2025), +10.1% vs $661M a year earlier, per its 10-K filed Feb 2026.
- Was NeoGenomics profitable in FY2025?
- No: net income was −$108M and operating income −$116M in FY2025.
- What was NeoGenomics's revenue in Q3 2026?
- $209M (+11.4% vs a year earlier), per its Form 10-Q filed Oct 28, 2026.